Skip Navigation


ToxSci Advance Access originally published online on July 28, 2004
Toxicological Sciences 2004 82(1):124-128; doi:10.1093/toxsci/kfh234
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
82/1/124    most recent
kfh234v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wang, J.
Right arrow Articles by Chen, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, J.
Right arrow Articles by Chen, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences vol. 82 no. 1 © Society of Toxicology 2004; all rights reserved.

Time Course of cII Gene Mutant Manifestation in the Liver, Spleen, and Bone Marrow of N-Ethyl-N-Nitrosourea-Treated Big Blue Transgenic Mice

Jianyong Wang*,{dagger}, Xiaoli Liu*, Robert H. Heflich*,{dagger} and Tao Chen*,1

* Division of Genetic and Reproductive Toxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079; and {dagger} Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205

Received May 26, 2004; accepted July 26, 2004

The time between treatment and the appearance of mutants (mutant manifestation time) is a critical variable for in vivo transgenic mutation assays. There are, however, limited data describing the optimal sampling time for detecting mutations in various tissues of mutagen-treated animals. In this study, we investigated the time course of cII gene mutant induction in the liver, spleen, and bone marrow of Big Blue transgenic mice treated with N-ethyl-N-nitrosourea (ENU). Six-month-old female mice were treated with a single dose (120 mg/kg) of ENU, and the animals were sacrificed, and the cII mutant frequencies (MFs) were determined at 1, 3, 7, 15, 30, and 120 days after the treatment. The MFs in the liver cII gene of ENU-treated mice increased with time after the treatment, while the MFs for concurrent controls remained constant. The liver cII MFs in ENU-treated mice were significantly increased at day 30 and 120 (p < 0.01), with the largest increase at day 120. The spleen cII MFs in ENU-treated mice were increased significantly at day 7 and later (p < 0.01), and reached a plateau at day 30. In the bone marrow, the cII MFs in ENU-treated mice were increased significantly at all sampling times (p < 0.01), with the maximum MF at day 3. These results confirm that the time after treatment required to reach the maximum MF is tissue specific, with the approximate time for the maximum ENU-induced cII MF response being: bone marrow, 3 days; spleen, 14–30 days; and liver, more than 30 days.

Key Words: Big Blue transgenic mice; N-ethyl-N-nitrosourea; mutation assay; mutant manifestation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
MutagenesisHome page
C. R. Valentine, H. F. Rainey, J. M. Farrell, J. G. Shaddock, V. N. Dobrovolsky, and R. R. Delongchamp
Frequency and spectrum of ENU-induced mutation in the {Phi}X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies
Mutagenesis, September 1, 2008; 23(5): 383 - 397.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
S. Ro and B. Rannala
Inferring Somatic Mutation Rates Using the Stop-Enhanced Green Fluorescent Protein Mouse
Genetics, September 1, 2007; 177(1): 9 - 16.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.